Moreover, albumin fusion technology has been used to obtain both long-acting insulin analogues [42] and HSA-fusion products with Tregitope peptides and insulin peptides useful in the treatment of Type 1 Diabetes [43]. This evidence concerns the gene ALB and type 1 diabetes mellitus.